Yüklüyor......
Adverse effects of SGLT2 inhibitors on bone
Sodium–glucose cotransporter 2 (SGLT2) inhibitors offer attractive metabolic and cardiorenal benefits for patients with type 2 diabetes, but are associated with a number of safety issues. A recent study documented that SGTL2 inhibition indirectly triggers the FGF23/1,25-dihydroxyvitamin D/parathyroi...
Kaydedildi:
| Yayımlandı: | Nat Rev Nephrol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6138556/ https://ncbi.nlm.nih.gov/pubmed/29875481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41581-018-0028-0 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|